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1 Introduction
For many years obstetricians have had the impres-
sion that certain pregnancy complications appear
to be associated with an unusually low incidence
of neonatal respiratory distress syndrome (RDS).
Why this should be is unclear but it was proposed
that "fetal stress" arising from a hostile intrauter-
ine environment was a likely underlying factor.





— preterm rupture of membranes,
— intrauterine growth retardation.
The effect of diabetes mellitus on the incidence of
RDS also remains undecided but in general it has
been suggested that this condition may delay or
alter surfactant production.
Unfortunately the problems of neonatal respirat-
ory disease and the influence of obstetric factors
are complicated by a number of issues. Firstly the
best indicator of mature fetal/neonatal lungs must
be decided. Should it be the presence of adequate
surfactant levels in the amniotic fluid/pharyngeal
aspirate or should the neonatal respiratory per-
formance be of greater importance? Secondly,
how certainly can a diagnosis of RDS be made
and are the criteria in current use relevant? Thirdly
how important are other factors, such as mode of
delivery, condition at birth and the vigor of the
neonatal resuscitation, in influencing neonatal
functional maturity? Finally, how is it possible to
derive a "normal" timetable for fetal lung matur-
ity using prematurely born babies who, by defini-
tion, are not normal either because of the time of
their birth or underlying maternal pathology.
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Biochemical methods to evaluate amniotic fluid
for evidence of fetal lung maturity have been in
use for a number of years. In a study completed
a few years ago [5] we demonstrated that, in the
presence of preterm rupture of the membranes
(PROM), a significantly greater proportion of am-
niotic fluids contained the surfactant, phosphati-
dylglycerol (PG). Other "stressful conditions"
however did not show this phenomenon suggest-
ing that PROM produced a specific stimulus to
surfactant production.
Why should this be? We established a hypothesis
that the fetal stress products, cortisol and the
catecholamines, may affect surfactant production
and release, to produce optimal lung function. A
prospective study was undertaken using pregnanc-
ies which terminated at or before 35 weeks [2].
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2 Material and methods
A total of 189 babies was studied in an attempt
to correlate obstetric complications with outcome
and a number of biochemical parameters includ-
ing amniotic/pharyngeal fluid surfactant and cord
blood artery and vein cortisol, adrenaline, nora-
drenaline and gases. The complications studied
were hypertension/proteinuria, vaginal bleeding,
preterm labor/ruptured membranes, abnormal an-
tenatal cardiotocography and small for gesta-
tional age.
Amniotic/pharyngeal fluids were collected when-
ever possible. Some of the amniotic fluids were
collected from the vagina and it was not always
possible to obtain material within 72 hours of
delivery. Amniotic/pharyngeal fluids were an-


























alyzed by two-dimensional thin layer chromato-
graphy (2-DTLC) technique [6] and when possible
the lecithin and phosphatidylglycerol was quanti-
fied from the phosphate concentration measured
in the eluted spots [3].
Cortisol levels were measured using a radioim-
mune assay kit (Amersham International, UK)
and the catecholamines were assayed by a radioen-
zymatic method [1]. Blood pH was measured in
the cord bloods using standard laboratory equip-
ment.
The non-parametric statistics involved chi-
squared analysis and differences between means
was determined using Student's t test.
3 Results
Table I shows the overall results for the study.
Tables II, III and IV show the effect of the obstet-
ric complications on outcome for three arbitrarily
selected gestational ages groups. There are more
numbers here because some pregnancies were
complicated by more than one problem and it was
often impossible to assign one major complication
to a single case. Nevertheless, none of the compli-
cations appear to have any striking effect on the
incidence of RDS, death or the presence of PG.
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PG = Phosphatidylglycerol in all the tables
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Tables V, VI and VII relate the complications to
arterial cord blood biochemistry. Again there were
no obviously significant changes but it was appar-
ent that very large standard deviations existed,
particularly for the catecholamines. Under these
circumstances the numbers involved are probably
too small to enable firm conclusions to be drawn.
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4 Discussion
The data presented here do not support the view
that certain obstetric complications accelerate
fetal lung maturity. There was a slight increase in
the numbers of cases with PROM who showed
PG in their fluids but this did not reach statistical
significance. In addition there did not seem to be
a relationship between the so-called stress factors
and pregnancy complication.
The best predictor of outcome was the gestational
age at which the baby was born. However, some
very immature babies with PG in their amniotic
fluid still developed severe respiratory disease
underlining the difficulties of diagnosis at this
gestational age when ventilatory support is com-
monly required. Nevertheless, those babies with
PG tended to have a more benign course, with
fewer complications, and this has been confirmed
in a separate study [4].
Whether obstetric complications influence neo-
natal outcome remains debateable. Probably ges-
tational age at the time of delivery and the baby's
condition at birth are as important.
Abstract
Obstetric complications have been associated with accel-
erated fetal lung maturity. In a prospective study involv-
ing 189 babies born before 36 weeks no specific obstetric
complication was observed to have a significant influ-
ence on neonatal respiratory function. In addition fetal
stress factors did not seem to contribute to eventual
outcome.
Keywords: Neonatal respiratory distress syndrome, pregnancy complications, surfactant.
Zusammenfassung
Schwangerschaftsbedingte Faktoren und Erkrankungen
mit Wirkung auf den Surfactant
In der vorliegenden Studie wurde der Einfluß verschiede-
ner geburtshilflicher Komplikationen auf die Surfactant-
produktion und die Inzidenz eines RDS beim Neugebo-
renen untersucht. Darüber hinaus wurden die Auswir-
kungen dieser Komplikationen auf die Kortisol- und
Katecholaminausschüttung als „Streßprodukte" beob-
achtet.
Wir untersuchten 189 Kinder mit weniger als 36 Schwan-
gerschaftswochen. Gemessen wurde die Surfactantkon-
zentration im Fruchtwasser und im Sekret aus dem
Pharynx; in Nabelarterie und -vene wurden die Kortisol-
und Katecholaminkonzentration sowie die Blutgase be-
stimmt. Bei den Komplikationen wurden berücksichtigt:
Hypertonus/Proteinurie, vaginale Blutung, Frühgeburt,
vorzeitiger Blasensprung, pathologisches CTG und in-
trauterine Mangelentwicklung.
Es gab keinen statistisch signifikanten Zusammenhang
zwischen diesen Komplikationen und einer akzelerierten
Surfactantproduktion bzw. einer geringeren Inzidenz
eines RDS. Neugeborene, bei denen im Fruchtwasser
bzw. im Pharynxsekret Phosphatidylglycerol nachgewie-
sen werden konnte, hatten eine günstigere neonatale
Prognose.
Wir folgern daraus, daß Schwangerschaftskomplikatio-
nen per se das neonatale Outcome anscheinend nicht
wesentlich beeinflussen. Wichtig ist das Schwanger-
schaftsalter zum Zeitpunkt der Geburt. Der Spiegel der
im Nabelschnurblut gemessenen „Streßhormone" wies
keine Beziehung zu den Schwangerschaftskomplikatio-
nen oder zur neonatalen Lungenfunktion auf. Die Studie
konnte nicht klären, durch welche Mechanismen die
menschliche fetale Lunge funktioneil reift.
Schlüsselwörter: Neonatales RDS, Schwangerschaftskomplikationen, Surfactant.
Resume
Facteurs lies a la grossesse et maladies influencant le
surfactant
Cette etude a ete menee pour determiner Feffet de certai-
nes complications obstetricales sur la production de sur-
factant et Fincidence du syndrome de detresse respira-
toire neonatale (SDR). En outre, on a observe 1'effet
de ces diverses complications sur les produits de la
« souffrance » foetale: Cortisol et catecholamines.
189 enfants au total ont ete etudies, tous nes avant 36
semaines. On a mesure le surfactant dans le liquide
amniotique pharynge et on a dose le Cortisol, les catechol-
amines et les gaz du sang dans la veine et dans Fartere
ombilicale. Les complications etudiees comprenaient:
hypertension arterielle, proteinurie, metrorragies, accou-
chement premature/rupture des membranes, anomalies
cardiotocographiques et hypotrophie.
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Les resultats n'ont pas permis de montier un effet signifi-
catif sur le plan statistique de ces complications ni en
terme d'acceleration de Fapparition du surfactant, ni en
terme de diminution du SDR. Les nouveaux-nes dont le
liquide amniotique pharynge contient du phosphatidyl-
glycerol ont un devenir neonatal moins grave.
Les conclusions de cette etude sont que les complications
de la grossesse en elles-memes n'apparaissent pas in-
fluencer significativement le devenir neonatal. Le facteur
principal est Tage gestationnel au moment de la nais-
sance. Les taux des produits du « stress »trouves au sang
du cordon ne sont pas correles aux complications de
la grossesse ni aux functions des poumons en periode
neonatale. Les mecanismes par lesquels le poumon du
foetus human devient fonctionellement mature n'ont pas
ete elucides par cette etude.
Mots-cles: Complications de la grossesse, surfactant, syndrome de detresse respiratoire neonatale.
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